Skip to content
healthcare.dev

Tranexamic Acid

NDC 69918-301, Tranexamic Acid, tablet, from Nordic Pharma, Inc..

Product NDC
69918-301
Status
Listed
Labeler
Nordic Pharma, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022430
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69918-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRANEXAMIC ACID650 mg/1

Pharmacologic classes

Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]

Package NDCNDC-11Package
69918-301-306991803013030 TABLET in 1 BOTTLE (69918-301-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/031bf7c2-3b07-469d-bc5a-31fc6238e25f
  • NADAC price for package 69918030130

    GET /v1/drugs/nadac/69918030130

Use it

Look up 69918-301 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69918-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69918-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.